Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.33 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.33 |
| ▸ | PTGIR | P43119 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MMP12 | P39900 | 2/20 | 0.30 |
| ▸ | MMP13 | P45452 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12206581 | 0.94 | GPR3 (0.42) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL26851688 | 0.93 | ALDH1A1 (0.41) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL24154585 | 0.92 | MAPT (0.41) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL26045551 | 0.90 | HPRT1 (0.36) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL12206584 | 0.90 | HPRT1 (0.36) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL16683252 | 0.90 | GPR3 (0.36) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL26851690 | 0.89 | ALDH1A1 (0.44) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL12206586 | 0.88 | GPR3 (0.35) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL27366726 | 0.88 | GPR3 (0.39) | GPR3MAPTALDH1A1HPGDRAB9A | |
| SCHEMBL21261400 | 0.86 | KDM1A (0.32) | GPR3ALDH1A1HPGDPTPN7DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11322705-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-03 | — | — | US | disclosed |
| US-11124521-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-09-21 | — | — | US | disclosed |
| US-20210257575-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-08-19 | — | — | US | disclosed |
| US-20190315760-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMNITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-10-17 | — | — | US | disclosed |
| US-20160308138-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
| US-20160308138-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11124521-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNT1 | GPR3 2252/4885MAPT 1525/4885ALDH1A1 198/4885 |
| US-20190315760-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMNITTING DEVICE INCLUDING THE SAME | CCNT1, CRY1, CCNT2 | GPR3 2629/4885MAPT 507/4885ALDH1A1 363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.